UNSPSC 85445605: The diagnosis of predominantly alpha-adrenoreceptor agonists

In this classification, this covers the group of activities that yields a diagnosis of predominantly alpha-adrenoreceptor agonists, not elsewhere classified. Predominantly alpha-adrenoreceptor agonists, not elsewhere classified is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y51.4.

UNSPSC 85445605 Diagnosis of predominantly alpha-adrenoreceptor agonists (Commodity) shows a significant mismatch between its nominal pharmaceutical classification and actual state and local procurement activity under the code. Recent opportunities tagged to this code do not involve pharmaceutical diagnosis or alpha-adrenoreceptor agonists at all; instead, they span diagnostic imaging systems, special education contracted services, and temporary health professional staffing — none of which align with the code's stated scope. The San Mateo Medical Center solicitation for a Picture Archiving and Communication System (PACS) involves enterprise radiology and cardiology imaging software migration, not pharmaceutical diagnostics. The Birdville Independent School District opportunity solicits speech language therapists, occupational therapists, diagnosticians, and other specialized education support services. The Santa Clara Health System qualification vehicle seeks temporary staffing for audiology, diagnostic imaging, respiratory care, and surgical services. None of these activities involve pharmaceutical products or alpha-adrenoreceptor agonist diagnosis.

State and local issuers applying this code span county health systems (San Mateo County, Santa Clara County), independent school districts (Birdville ISD in Texas), and their respective public health and education operations. The geographic breadth includes California (San Mateo and Santa Clara Counties) and Texas (Tarrant County). The code shows little relevant recent activity aligned with its pharmaceutical classification; the mismatch suggests either miscategorization by issuing bodies or that this particular UNSPSC code does not accurately reflect current state and local buying patterns in clinical or educational diagnostics. Business development professionals should treat opportunities surfacing under this code with skepticism, verify the actual scope against the UNSPSC definition, and confirm whether the code assignment reflects a procurement office error or a legitimate reclassification of the work being solicited.